Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021574 220018165 null null Curative (C) 2016-01-25 2016-01-25 Cytarabine+Methotrexate Intrathecal null null 220035329 SPANISH MAINTENANCE
220021575 220014964 null 48.1 Palliative (P) 2013-07-14 2013-07-14 MYELOMA XI TRIAL Y null 220035347 CYCLOPHOSPHAMIDE HIGH DOSE
220021576 220009361 1.85 78.2 Curative (C) 2018-04-19 2018-04-24 Lenalidomide 25mg (Cycle 1 to 25) N N 220035373 RAVVA TRIAL
220021577 220009364 1.7 95.5 Palliative (P) null 2018-03-06 Alemtuzumab+Busulfan+CyclophosphMUD N N 220035392 BUSULFAN + CYCLOPHOSPHAMIDE + FLUDARABINE
220021578 220009368 1.67 60 Curative (C) 2017-08-09 2017-08-09 PEMBROLIZUMAB N N 220035406 VINORELBINE
220021579 220009373 1.67 65.8 Curative (C) 2016-04-15 2016-04-15 BUSULFAN + MELPHALAN 2 N 220035412 DABRAFENIB
220021580 220009379 null 102.4 Palliative (P) 2014-10-10 2014-10-10 CAV N N 220035414 DABRAFENIB + TRAMETINIB
220021582 220009410 1.57 50.3 Curative (C) 2015-08-14 2015-10-05 Capecitabine N N 220035549 UKALL60+
220021583 220009414 null 64.9 Curative (C) null 2018-03-31 Etoposide oral N N 220035566 ARSENIC TRIOXIDE + ATRA
220021584 220009425 1.68 45 Curative (C) null 2015-03-14 OSIMERTINIB N null 220035632 FLUDARABINE
220021585 220015002 1.6 76 Disease modification (D) 2015-09-29 2015-10-04 RAVVA TRIAL 02 N 220035672 DACTINOMYCIN
220021587 220018196 1.71 80 Disease modification (D) null 2015-02-14 CARFILZOMIB 01 N 220035925 ARSENIC TRIOXIDE
220021588 220009475 null null Curative (C) 2017-10-07 2017-11-07 Depocyte Intrathecal N N 220035947 UKALL2011
220021589 220009493 1.56 68 Palliative (P) 2015-06-09 2015-06-10 DABRAFENIB + TRAMETINIB 01 N 220036034 LENALIDOMIDE
220021590 220009500 1.64 89 Curative (C) 2016-04-04 2016-04-04 MACE 02 N 220036062 CAPECITABINE
220021591 220009510 1.55 68.3 Curative (C) 2015-12-20 2015-12-24 CYTARABINE + MITOXANTRONE 01 N 220036121 GANETESPIB
220021593 220021928 1.6 78.4 Curative (C) 2017-11-08 2017-11-08 Ipilimumab 02 N 220036280 CETUXIMAB + RT
220021594 220009579 1.74 44.4 null 2018-08-07 2018-08-13 ALL Int Guide A/B/C Maint Ph V N N 220036432 FLUOROURACIL
220021595 220009595 null 72.5 Curative (C) 2017-05-18 2017-05-30 GCLAC N N 220036524 CYCLOPHOSPHAMIDE HIGH DOSE
220021597 220009621 null null Curative (C) 2014-10-09 2014-10-09 ALEMTUZUMAB + FLUDARABINE N N 220036606 CISPLATIN
220021598 220009642 1.64 64.3 Disease modification (D) 2015-03-29 2015-04-06 Trastuzumab 21 day maintenance N N 220036641 CAPECITABINE + OXALIPLATIN
220021599 220015100 null 78.8 Curative (C) null 2018-08-29 ALL Int Gde A/B DInt PhIV pt1 PAsp 2 N 220036683 CYCLOPHOSPHAMIDE HIGH DOSE
220021600 220009682 1.75 68.45 null 2012-10-15 2014-01-12 VINORELBINE 2 N 220000653 FIGARO TRIAL
220021601 220009685 1.71 78 Curative (C) 2016-07-25 2016-07-26 Sorafenib 02 N 220002814 LENALIDOMIDE
220021602 220009691 1.83 69 Curative (C) 2017-07-14 2017-11-10 VINORELBINE 02 N 220004682 MITOXANTRONE + TRETINOIN
220021603 220015121 1.64 48.8 null 2018-12-01 2019-01-08 MACE N N 220014128 CAPECITABINE + OXALIPLATIN
220021604 220009715 null 103.4 Palliative (P) 2017-12-25 2018-07-06 R GCVP N null 220018242 BUSULFAN + CYCLOPHOSPHAMIDE
220021605 220009744 null null Curative (C) 2015-10-29 2015-11-02 Cytarabine+Methotrexate Intrathecal null N 220022881 MELPHALAN
220021606 220009775 null null Curative (C) 2019-08-04 2019-10-27 MITOMYCIN 01 N 220029686 FIGARO TRIAL
220021607 220009783 null 112.4 Curative (C) 2018-03-29 2018-03-29 Etoposide IV N null 220032124 CARBOPLATIN + RT
220021608 220009786 null 81.3 Disease modification (D) 2018-09-05 2018-12-15 MITOXANTRONE + TRETINOIN 02 N 220032395 CYTARABINE IT + METHOTREXATE
220021609 220009796 1.63 63 Curative (C) 2015-07-13 2015-07-24 MACE N N 220034048 PEMBROLIZUMAB
220021610 220009806 0 126 Curative (C) 2015-07-08 2015-07-08 Arsenic Triox + Tretinoin Ind W1-4 2 N 220034508 BUSULPHAN + CYCLO
220021611 220009813 1.6 66 null 2017-09-18 2017-09-18 Midostaurin 2 N 220035216 FCR
220021612 220009830 1.6 56.5 Disease modification (D) 2019-06-21 2019-10-10 CHOP - 21 days 2 N 220026545 ETOPOSIDE
220021613 220004062 null 78.5 Disease modification (D) 2016-12-29 2017-01-05 IMATINIB N N 220000242 IMATINIB
220021615 220004071 1.83 78.5 Palliative (P) 2017-10-21 2017-10-22 IMATINIB N N 220000450 IMATINIB
220021616 220004088 1.66 87 Curative (C) 2017-10-11 2017-10-12 IMATINIB null N 220001016 IMATINIB
220021617 220004100 0 0 Disease modification (D) 2016-05-03 2017-09-10 Imatinib 400mg null N 220001182 IMATINIB
220021624 220004256 1.8 0 Palliative (P) 2015-10-24 2019-01-06 Imatinib 400mg N N 220004877 IMATINIB
220021626 220004350 null null Disease modification (D) 2014-05-23 2014-05-23 IMATINIB null null 220007267 IMATINIB
220021627 220004369 null 97.3 Curative (C) 2014-01-25 2014-01-25 Imatinib 600mg 2 N 220007789 IMATINIB
220021628 220016687 null null Palliative (P) null 2017-04-09 IMATINIB null null 220007957 IMATINIB
220021629 220020580 0 124.6 Disease modification (D) 2015-10-25 2016-11-22 IMATINIB 02 N 220008330 IMATINIB
220021630 220004405 1.7 95.5 Disease modification (D) 2015-09-22 2015-09-25 IMATINIB null N 220008562 IMATINIB
220021633 220004460 1.77 68.8 Curative (C) 2016-02-01 2016-03-23 DA 3+8 N N 220009894 DA
220021634 220004474 1.78 80.5 Curative (C) 2014-09-22 2014-11-16 DA 02 N 220010339 DA
220021635 220004477 1.66 62.7 Curative (C) null 2017-03-21 DA 3+8 N N 220010374 DA
220021636 220020590 -1 119 Palliative (P) 2017-04-04 2018-12-14 Azacitidine 01 N 220010587 AZACITIDINE
220021637 220004487 1.59 110.6 Curative (C) 2017-09-05 2017-09-07 DA N Y 220010668 DA